Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1Ā 091,51
-2,30
-0,21%
ā€”1Ā 093,811Ā 096,521Ā 100,221Ā 091,51ā€”ā€”
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
ā€”608,77608,77612,97608,77ā€”ā€”
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1Ā 237,98
-16,83
-1,34%
ā€”1Ā 254,811Ā 253,011Ā 253,871Ā 226,33ā€”ā€”
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1Ā 744,71
-16,40
-0,93%
ā€”1Ā 761,111Ā 764,271Ā 766,881Ā 744,71ā€”ā€”
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
ā€”642,58644,87648,48640,18ā€”ā€”
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
ā€”851,13855,66858,75845,56ā€”ā€”
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
ā€”217,98217,98218,65216,88ā€”ā€”
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3Ā 260,69
+48,86
+1,52%
ā€”3Ā 211,833Ā 227,213Ā 268,383Ā 226,55ā€”ā€”
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
ā€”948,98948,58957,83941,97ā€”ā€”
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1Ā 466,80
-7,72
-0,52%
ā€”1Ā 474,521Ā 479,031Ā 481,041Ā 466,80ā€”ā€”
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2Ā 397,50
+5,38
+0,22%
ā€”2Ā 392,122Ā 396,952Ā 421,222Ā 382,32ā€”ā€”
Q1 2026 earnings ā€¢ released ā€¢ EPS beat +11,14% ā€¢ Revenue beat +5,24%
See results
BMY:NYSE
Bristol-Myers Squibb Co
58,22Ā US$
-3,91%
(-2,37) 1D
58,50Ā US$
+0,48% (+0,28)
After hours
Closed: 1 įƒ›įƒįƒ˜, 16:00:04 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BMY...
Open
60,02Ā US$
High
60,08Ā US$
Low
58,03Ā US$
Mkt. cap
118,87Ā įƒ›įƒšįƒ .
Volume
18,37Ā įƒ›įƒšįƒœ.
Dividend
4,33%
Quarterly dividend
0,63Ā US$
Ex dividend date
2 įƒ˜įƒįƒœ. 2026
P/E ratio
16,34
52-wk high
62,89Ā US$
52-wk low
42,52Ā US$
EPS
3,56Ā US$
Beta
0,27
Shares outstanding
2,04Ā įƒ›įƒšįƒ įƒ“.
No. of employees
32Ā įƒįƒ—.
News stories
From sources across the web
Simply Wall Street
Simply Wall Street
·
13 įƒ”įƒįƒįƒ—įƒ˜įƒ” įƒ¬įƒ˜įƒœ
Bristol Myers Squibb (BMY) Margin Strength In Q1 2026 Challenges Bearish Earnings Narratives
MarketBeat
MarketBeat
·
16 įƒ”įƒįƒįƒ—įƒ˜įƒ” įƒ¬įƒ˜įƒœ
Bristol Myers Squibb Company $BMY Shares Sold by Danske Bank A S
MarketBeat
MarketBeat
·
17 įƒ”įƒįƒįƒ—įƒ˜įƒ” įƒ¬įƒ˜įƒœ
Artemis Investment Management LLP Takes Position in Bristol Myers Squibb Company $BMY
Seeking Alpha
Seeking Alpha
·
17 įƒ”įƒįƒįƒ—įƒ˜įƒ” įƒ¬įƒ˜įƒœ
Bristol Myers Squibb: The CAR-T Giant The Market Is Undervaluing (NYSE:BMY)
Profile
Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban for people with atrial fibrillation; nivolumab, used to treat certain types of cancer; lenalidomide, used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes; abatacept, used to treat autoimmune diseases such as rheumatoid arthritis; pomalidomide, an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma; ipilimumab, to treat cancer; and luspatercept for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2024, 71% of the company's revenues came from the United States. The company is ranked 94th on the Fortune 500 and 173rd on the Forbes Global 2000. Wikipedia
About Bristol-Myers Squibb Co
CEOįƒ„įƒ įƒ˜įƒ” įƒ‘įƒ”įƒ įƒœįƒ”įƒ įƒ˜
Employees32,5Ā įƒįƒ—.
Founded1887
Headquartersįƒœįƒ˜įƒ£-įƒ˜įƒįƒ įƒ™įƒ˜, įƒœįƒ˜įƒ£-įƒ˜įƒįƒ įƒ™įƒ˜įƒ” įƒØįƒ¢įƒįƒ¢įƒ˜, įƒįƒ›įƒ”įƒ įƒ˜įƒ™įƒ˜įƒ” įƒØįƒ”įƒ”įƒ įƒ—įƒ”įƒ‘įƒ£įƒšįƒ˜ įƒØįƒ¢įƒįƒ¢įƒ”įƒ‘įƒ˜
SectorPharmaceutical industry
Websitebms.com
Last report
30 įƒįƒžįƒ . 2026
Fiscal Period
Q1 2026
Normalized EPS / Estimate
1,58/ (1,42 est.)USD
+11,14%beat
Revenue / Estimate
11,49Ā įƒ›įƒšįƒ įƒ“./ (10,92Ā įƒ›įƒšįƒ įƒ“. est.)USD
+5,24%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
įƒ˜įƒ•įƒœ. 2025
įƒ”įƒ”įƒ„. 2025
įƒ“įƒ”įƒ™. 2025
įƒ›įƒįƒ . 2026
Revenue
12,27Ā įƒ›įƒšįƒ įƒ“.
12,22Ā įƒ›įƒšįƒ įƒ“.
12,50Ā įƒ›įƒšįƒ įƒ“.
11,49Ā įƒ›įƒšįƒ įƒ“.
Cost of goods sold
3,36Ā įƒ›įƒšįƒ įƒ“.
3,31Ā įƒ›įƒšįƒ įƒ“.
3,51Ā įƒ›įƒšįƒ įƒ“.
3,42Ā įƒ›įƒšįƒ įƒ“.
Cost of revenue
3,36Ā įƒ›įƒšįƒ įƒ“.
3,31Ā įƒ›įƒšįƒ įƒ“.
3,51Ā įƒ›įƒšįƒ įƒ“.
3,42Ā įƒ›įƒšįƒ įƒ“.
Research and development expenses
2,26Ā įƒ›įƒšįƒ įƒ“.
2,43Ā įƒ›įƒšįƒ įƒ“.
2,56Ā įƒ›įƒšįƒ įƒ“.
2,65Ā įƒ›įƒšįƒ įƒ“.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,69Ā įƒ›įƒšįƒ įƒ“.
1,79Ā įƒ›įƒšįƒ įƒ“.
2,09Ā įƒ›įƒšįƒ įƒ“.
1,62Ā įƒ›įƒšįƒ įƒ“.
Operating expense
4,78Ā įƒ›įƒšįƒ įƒ“.
5,05Ā įƒ›įƒšįƒ įƒ“.
5,47Ā įƒ›įƒšįƒ įƒ“.
4,70Ā įƒ›įƒšįƒ įƒ“.
Total operating expenses
8,14Ā įƒ›įƒšįƒ įƒ“.
8,36Ā įƒ›įƒšįƒ įƒ“.
8,98Ā įƒ›įƒšįƒ įƒ“.
8,12Ā įƒ›įƒšįƒ įƒ“.
Operating income
4,13Ā įƒ›įƒšįƒ įƒ“.
3,86Ā įƒ›įƒšįƒ įƒ“.
3,52Ā įƒ›įƒšįƒ įƒ“.
3,36Ā įƒ›įƒšįƒ įƒ“.
Other non operating income
399,00Ā įƒ›įƒšįƒœ.
529,00Ā įƒ›įƒšįƒœ.
544,00Ā įƒ›įƒšįƒœ.
-32,00Ā įƒ›įƒšįƒœ.
EBT including unusual items
1,77Ā įƒ›įƒšįƒ įƒ“.
3,11Ā įƒ›įƒšįƒ įƒ“.
1,47Ā įƒ›įƒšįƒ įƒ“.
3,24Ā įƒ›įƒšįƒ įƒ“.
EBT excluding unusual items
4,22Ā įƒ›įƒšįƒ įƒ“.
4,07Ā įƒ›įƒšįƒ įƒ“.
3,86Ā įƒ›įƒšįƒ įƒ“.
3,33Ā įƒ›įƒšįƒ įƒ“.
Income tax expense
460,00Ā įƒ›įƒšįƒœ.
919,00Ā įƒ›įƒšįƒœ.
384,00Ā įƒ›įƒšįƒœ.
561,00Ā įƒ›įƒšįƒœ.
Effective tax rate
25,96%
29,51%
26,12%
17,32%
Other operating expenses
-
-
-
-
Net income
1,31Ā įƒ›įƒšįƒ įƒ“.
2,20Ā įƒ›įƒšįƒ įƒ“.
1,09Ā įƒ›įƒšįƒ įƒ“.
2,68Ā įƒ›įƒšįƒ įƒ“.
Net profit margin
10,68%
18,01%
8,69%
23,30%
Earnings per share
1,46
1,63
1,26
1,58
Interest and investment income
139,00Ā įƒ›įƒšįƒœ.
161,00Ā įƒ›įƒšįƒœ.
148,00Ā įƒ›įƒšįƒœ.
-
Interest expense
-485,00Ā įƒ›įƒšįƒœ.
-482,00Ā įƒ›įƒšįƒœ.
-432,00Ā įƒ›įƒšįƒœ.
-
Net interest expenses
-346,00Ā įƒ›įƒšįƒœ.
-321,00Ā įƒ›įƒšįƒœ.
-284,00Ā įƒ›įƒšįƒœ.
-
Depreciation and amortization charges
-
-
-
-
EBITDA
5,12Ā įƒ›įƒšįƒ įƒ“.
4,91Ā įƒ›įƒšįƒ įƒ“.
4,54Ā įƒ›įƒšįƒ įƒ“.
3,96Ā įƒ›įƒšįƒ įƒ“.
Gain or loss from assets sale
-7,00Ā įƒ›įƒšįƒœ.
-9,00Ā įƒ›įƒšįƒœ.
-
-34,00Ā įƒ›įƒšįƒœ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer